Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)
| 2.42 Delayed Data As of 5:25pm ET |  -0.35 / -12.64%Today’s Change | 1.12 Today|||52-Week Range 11.30 | +21.61% Year-to-Date |
Latest SNSS News | Press Releases
No recent news for Sunesis Pharmaceuticals Inc.
Today’s Trading
| Previous close | 2.77 |
| Today’s open | 3.03 |
| Day’s range | 2.35 - 2.83 |
| Volume | 71,416 |
| Average volume (3 months) | 1,009,619 |
| Market cap | $64.5M |
Data as of 5:25pm ET, 01/27/2021
Growth & Valuation
| Earnings growth (last year) | +64.20% |
| Earnings growth (this year) | +71.36% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +774.68% |
| P/E ratio | NM |
| Price/Sales | 14.19 |
| Price/Book | 2.51 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OPNTOpiant Pharmaceutica... | -1.23 | -10.18% |
| CPIXCumberland Pharmaceu... | -0.07 | -2.15% |
| KTRAKintara Therapeutics... | -0.22 | -10.38% |
| PULMPulmatrix Inc | -0.09 | -6.00% |
Data as of 4:46pm ET, 01/27/2021
Financials
| Next reporting date | March 11, 2021 |
| EPS forecast (this quarter) | -$0.28 |
| Annual revenue (last year) | $2.1M |
| Annual profit (last year) | -$23.3M |
| Net profit margin | -1,125.42% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
